Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Exosomal non-coding RNAs: gatekeepers of inflammation in autoimmune disease

Mohamed J. SaadhFaculty of Pharmacy, Middle East University, Amman, 11831, Jordan. [email protected]Omer Qutaiba B. AllelaCollege of Pharmacy, Alnoor University, Nineveh, IraqAli Fawzi Al-HussainyCollege of Pharmacy, Ahl Al Bayt University, Kerbala, IraqLalji BaldaniyaDepartment of Pharmacy, Faculty of Health Sciences, Marwadi University Research Center, Marwadi University, Rajkot, Gujarat, 360003, IndiaM. M. RekhaDepartment of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, IndiaDeepak NathiyaDepartment of Pharmacy Practice, Institute of Pharmacy, NIMS University Rajasthan, Jaipur, IndiaParjinder KaurChandigarh Pharmacy College, Chandigarh Group of Colleges-Jhanjeri, Mohali, Punjab, 140307, IndiaZafar AminovDepartment of Public Health and Healthcare management, Samarkand State Medical University, 18 Amir Temur Street, Samarkand, UzbekistanHayder Naji SameerCollage of Pharmacy, National University of Science and Technology, Dhi Qar, 64001, IraqHuda Ghassan HameedZainab H. AthabDepartment of Pharmacy, Al-Zahrawi University College, Karbala, IraqMohaned AdilPharmacy College, Al-Farahidi University, Baghdad, Iraq
Journal of Inflammationjournal2025en
ABI

Аннотация

Autoimmune diseases (AIDs) are marked by systemic inflammation and immune dysregulation, yet current therapies often fail to target their underlying causes. Emerging evidence positions exosomal non-coding RNAs (ncRNAs)-including miRNAs, lncRNAs, and circRNAs-as key regulators of inflammatory pathways, providing critical insights into AID pathogenesis. This review synthesizes recent advances in how these ncRNAs orchestrate immune cell communication, modulate inflammatory mediators, and drive microglial activation in neuroinflammatory AIDs. It evaluates their dual role as disease amplifiers (e.g., miR-155 in lupus, miR-326 in rheumatoid arthritis) and therapeutic targets, emphasizing their potential to reprogram immune responses or deliver anti-inflammatory agents. In this review, we first provide a glimpse into the pathogenesis of autoimmune diseases and delve into the structure and function of exosomes, emphasizing their role in cell-cell communication. We then discuss the regulatory roles of exosomal ncRNAs in immune modulation, detailing their types, functions, and mechanisms of action. Finally, we examine the implications of exosomes and exosomal ncRNAs in the context of autoimmune diseases, with a particular focus on microglial activation and its contribution to neuroinflammation.

Перевод пока недоступен

Темы

Идентификаторы

Цитирования и источники